Breaking News

Why telehealth startups are steering clear of abortion pills

    

 

Weekend Reads

STAT Trials Pulse is a new clinical trials intelligence platform, built by AI company Applied XL and vetted by STAT’s national biotech team, that helps life sciences professionals identify the most important updates happening in the clinical trial space. Learn more and get started with a four-week free trial.

Wary of a backlash, telehealth startups focused on women's sexual health steer clear of abortion pills

By Olivia Goldhill

The abortion pill is a combination of mifepristone and misoprostol tablets. (ELISA WELLS/PLAN C/AFP via Getty Images)

The bitterly polarized debate around abortion and concerns about losing customers are major reasons some telehealth startups have avoided adding abortion pills to their services.

Read More

More great reads from STAT this week

Saturday, January 22, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments